Selvom carcinogenicitetspotentialet hos mennesker ikke er kendt, antyder disse data, at efavirenz 'kliniske fordele opvejer den mulige carcinogenicitet hos mennesker. ###>While the carcinogenic potential in humans is unknown, these data suggest that the clinical benefit of efavirenz outweighs the potential carcinogenic risk to humans.